S&P 500

5.277,51

0,80%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Eyetech Pharmaceuticals (MM) (EYET)
Eyetech Pharmaceuticals (MM) (EYET) Notícias

EYET

Eyetech (EYET)

Eyetech Pharmaceuticals (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:EYET

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
12/11/2005	20:52	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
10/11/2005	14:30	PR Newswire (US)	Eyetech Provides Update on Status of Pending Acquisition by OSI Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
31/10/2005	20:00	PR Newswire (US)	Eyetech Reports Third Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
17/10/2005	11:30	PR Newswire (US)	Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in Dia	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
05/10/2005	10:30	PR Newswire (US)	Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients Wit	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
16/09/2005	10:15	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
21/08/2005	21:48	PR Newswire (US)	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement	NASDAQ:EYET
21/08/2005	20:45	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be Acc	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
09/08/2005	10:30	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical Achievem	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
27/07/2005	18:30	PR Newswire (US)	Eyetech Reports Second Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
18/07/2005	15:30	PR Newswire (US)	Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists	NASDAQ:EYET
15/07/2005	14:30	PR Newswire (US)	Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
22/06/2005	09:30	PR Newswire (US)	Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
21/06/2005	16:33	PR Newswire (US)	Eyetech Vision Day to Preview Future of Macugen Franchise	NASDAQ:EYET
13/06/2005	20:34	PR Newswire (US)	Eyetech to Host Vision Day on Wednesday, June 22	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
10/06/2005	18:29	Business Wire	Schaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
10/06/2005	09:31	PR Newswire (US)	Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlin	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
09/06/2005	09:30	PR Newswire (US)	Eyetech Adopts Stockholder Rights Agreement	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
24/05/2005	22:30	PR Newswire (US)	Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
24/05/2005	09:30	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
10/05/2005	19:30	PR Newswire (US)	Eyetech to Present at the 2005 UBS Global Pharmaceuticals Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
05/05/2005	18:10	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
05/05/2005	11:19	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy Les	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
02/05/2005	18:10	PR Newswire (US)	Preclinical Study Demonstrates Significance of VEGF164 in Pathological Neovascularization	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
02/05/2005	18:10	PR Newswire (US)	Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMD	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
21/04/2005	18:30	PR Newswire (US)	Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
20/04/2005	19:09	PR Newswire (US)	Eyetech Reports First Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
07/04/2005	18:30	PR Newswire (US)	Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
07/04/2005	18:30	PR Newswire (US)	Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
18/03/2005	18:15	PR Newswire (US)	Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)